BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 35336057)

  • 1. N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis.
    Kim J; Kang C; Yoo JW; Yoon IS; Jung Y
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine and Chromotrope 2B reduce oxidative stress in murine bone marrow-derived mesenchymal stem cells.
    Iqbal H; Naeem N; Haneef K; Salim A
    Mol Biol Rep; 2023 May; 50(5):4119-4131. PubMed ID: 36877347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon-Targeted Trans-Cinnamic Acid Ameliorates Rat Colitis by Activating GPR109A.
    Kang C; Kim J; Ju S; Cho H; Kim HY; Yoon IS; Yoo JW; Jung Y
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
    Hanauer SB
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():37-40. PubMed ID: 16961743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of ulcerative colitis with a specific focus on 5-aminosalicylates.
    Freeman HJ
    Clin Med Insights Gastroenterol; 2012; 5():77-83. PubMed ID: 24833937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapsone Azo-Linked with Two Mesalazine Moieties Is a "Me-Better" Alternative to Sulfasalazine.
    Kang C; Kim J; Ju S; Park S; Yoo JW; Yoon IS; Kim MS; Jung Y
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
    Yang Y; Kim W; Kim D; Jeong S; Yoo JW; Jung Y
    Drug Des Devel Ther; 2019; 13():231-242. PubMed ID: 30643389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis.
    Kim W; Kim D; Jeong S; Ju S; Lee H; Kim S; Yoo JW; Yoon IS; Jung Y
    Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31703411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity.
    Jeong S; Lee H; Kim S; Ju S; Kim W; Cho H; Kim HY; Heo G; Im E; Yoo JW; Yoon IS; Jung Y
    Mol Pharm; 2020 Jan; 17(1):167-179. PubMed ID: 31743034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB.
    Kim W; Nam J; Lee S; Jeong S; Jung Y
    Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery.
    Kim D; Kim W; Jeong S; Kim D; Yoo JW; Jung Y
    Drug Deliv Transl Res; 2019 Feb; 9(1):334-343. PubMed ID: 30426357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of IKK-activated GSK3β inhibitory peptide as an inflammation-responsive anti-colitic therapeutic.
    Hong S; Ju S; Yoo JW; Ha NC; Jung Y
    Biomater Sci; 2021 Sep; 9(19):6584-6596. PubMed ID: 34582526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapsone Ameliorates Colitis through TLR4/NF-kB Pathway in TNBS Induced Colitis Model in Rat.
    Mohammad Jafari R; Shayesteh S; Ala M; Yousefi-Manesh H; Rashidian A; Hashemian SM; Sorouri M; Dehpour AR
    Arch Med Res; 2021 Aug; 52(6):595-602. PubMed ID: 33814208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and Evaluation of Colon-Targeted Prodrugs of the Microbial Metabolite 3-Indolepropionic Acid as an Anticolitic Agent.
    Lee H; Park S; Ju S; Kim S; Yoo JW; Yoon IS; Min DS; Jung Y
    Mol Pharm; 2021 Apr; 18(4):1730-1741. PubMed ID: 33661643
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.